Clinical Trial Update: Low-dose Challenge Model With Enterotoxigenic E Coli [Phase 1]

View source ↗

Summary

Phase 1 clinical trial using a low-dose enterotoxigenic Escherichia coli challenge model to study diarrhea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diarrhea

Snippet

Sponsor: Johns Hopkins Bloomberg School of Public Health | Conditions: Diarrhea | Phase 1 | Status: COMPLETED